CRISPR/Cas9-mediated correction of MITF homozygous point mutation in a Waardenburg syndrome 2A pig model
- PMID: 34094716
- PMCID: PMC8141604
- DOI: 10.1016/j.omtn.2021.04.009
CRISPR/Cas9-mediated correction of MITF homozygous point mutation in a Waardenburg syndrome 2A pig model
Abstract
Gene therapy for curing congenital human diseases is promising, but the feasibility and safety need to be further evaluated. In this study, based on a pig model that carries the c.740T>C (L247S) mutation in MITF with an inheritance pattern and clinical pathology that mimics Waardenburg syndrome 2A (WS2A), we corrected the point mutation by the CRISPR-Cas9 system in the mutant fibroblast cells using single-stranded oligodeoxynucleotide (ssODN) and long donor plasmid DNA as the repair template. By using long donor DNA, precise correction of this point mutation was achieved. The corrected cells were then used as the donor cell for somatic cell nuclear transfer (SCNT) to produce piglets, which exhibited a successfully rescued phenotype of WS2A, including anophthalmia and hearing loss. Furthermore, engineered base editors (BEs) were exploited to make the correction in mutant porcine fibroblast cells and early embryos. The correction efficiency was greatly improved, whereas substantial off-targeting mutations were detected, raising a safety concern for their potential applications in gene therapy. Thus, we explored the possibility of precise correction of WS2A-causing gene mutation by the CRISPR-Cas9 system in a large-animal model, suggesting great prospects for its future applications in treating human genetic diseases.
Keywords: CRISPR/Cas9; MITF; anophthalmia; base editor; gene correction; hearing loss.
© 2021 The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Creation of miniature pig model of human Waardenburg syndrome type 2A by ENU mutagenesis.Hum Genet. 2017 Nov;136(11-12):1463-1475. doi: 10.1007/s00439-017-1851-2. Epub 2017 Nov 1. Hum Genet. 2017. PMID: 29094203
-
CRISPR/Cas9-mediated genome editing of splicing mutation causing congenital hearing loss.Gene. 2019 Jun 30;703:83-90. doi: 10.1016/j.gene.2019.03.020. Epub 2019 Mar 18. Gene. 2019. PMID: 30898719
-
In Vitro Validation of a CRISPR-Mediated CFTR Correction Strategy for Preclinical Translation in Pigs.Hum Gene Ther. 2019 Sep;30(9):1101-1116. doi: 10.1089/hum.2019.074. Epub 2019 Jun 18. Hum Gene Ther. 2019. PMID: 31099266
-
CRISPR/Cas9-mediated correction of human genetic disease.Sci China Life Sci. 2017 May;60(5):447-457. doi: 10.1007/s11427-017-9032-4. Epub 2017 May 3. Sci China Life Sci. 2017. PMID: 28534256 Review.
-
CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review.Cells. 2020 Apr 16;9(4):993. doi: 10.3390/cells9040993. Cells. 2020. PMID: 32316223 Free PMC article. Review.
Cited by
-
The applications of CRISPR/Cas-mediated genome editing in genetic hearing loss.Cell Biosci. 2023 May 20;13(1):93. doi: 10.1186/s13578-023-01021-7. Cell Biosci. 2023. PMID: 37210555 Free PMC article. Review.
-
Multiple Genetic Loci Associated with Pug Dog Thoracolumbar Myelopathy.Genes (Basel). 2023 Feb 1;14(2):385. doi: 10.3390/genes14020385. Genes (Basel). 2023. PMID: 36833311 Free PMC article.
-
Towards human organ generation using interspecies blastocyst complementation: Challenges and perspectives for therapy.Front Cell Dev Biol. 2023 Jan 19;11:1070560. doi: 10.3389/fcell.2023.1070560. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 36743411 Free PMC article. Review.
-
Kidney ECM Pregel Nanoarchitectonics for Microarrays to Accelerate Harvesting Gene-Edited Porcine Primary Monoclonal Spheres.ACS Omega. 2022 Jun 29;7(27):23156-23169. doi: 10.1021/acsomega.2c01074. eCollection 2022 Jul 12. ACS Omega. 2022. PMID: 35847249 Free PMC article.
-
Advances in CRISPR-Based Functional Genomics and Nucleic Acid Detection in Pigs.Front Genet. 2022 May 31;13:891098. doi: 10.3389/fgene.2022.891098. eCollection 2022. Front Genet. 2022. PMID: 35711930 Free PMC article. No abstract available.
References
-
- Kochhar A., Hildebrand M.S., Smith R.J. Clinical aspects of hereditary hearing loss. Genet. Med. 2007;9:393–408. - PubMed
-
- Song J., Feng Y., Acke F.R., Coucke P., Vleminckx K., Dhooge I.J. Hearing loss in Waardenburg syndrome: A systematic review. Clin. Genet. 2016;89:416–425. - PubMed
-
- Ohno N., Kiyosawa M., Mori H., Wang W.F., Takase H., Mochizuki M. Clinical findings in Japanese patients with Waardenburg syndrome type 2. Jpn. J. Ophthalmol. 2003;47:77–84. - PubMed
-
- Tassabehji M., Newton V.E., Read A.P. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat. Genet. 1994;8:251–255. - PubMed
LinkOut - more resources
Full Text Sources
